SCHEMBL7743113

SCHEMBL7743113

NC(Cc1c[nH]c2ccccc12)C(=O)OCc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TACR1 P25103 6/20 0.66
▸ PTPRA P18433 1/20 0.55
▸ MEN1 O00255 3/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ MAPT P10636 3/20 0.55
▸ KDM4E B2RXH2 2/20 0.55
▸ LMNA P02545 1/20 0.55
▸ MPO P05164 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ BLM P54132 1/20 0.55
▸ PMP22 Q01453 1/20 0.55
▸ HIF1A Q16665 1/20 0.55
▸ CYP2C19 P33261 1/20 0.53
▸ ALDH1A1 P00352 1/20 0.52
▸ FAAH O00519 1/20 0.50
▸ TRPV1 Q8NER1 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ LNPEP Q9UIQ6 1/20 0.49
▸ PKM P14618 1/20 0.49
▸ PKLR P30613 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1167913 0.86 TACR1 (0.77) TACR1MEN1KMT2AMAPTKDM4E
SCHEMBL31119836 0.86 TACR1 (0.77) TACR1MEN1KMT2AMAPTKDM4E
SCHEMBL8025702 0.86 TACR1 (0.77) TACR1MEN1KMT2AMAPTKDM4E
SCHEMBL1167914 0.86 TACR1 (0.77) TACR1MEN1KMT2AMAPTKDM4E
SCHEMBL5970060 0.86 FAAH (0.61) TACR1PTPRAMEN1KMT2AMAPT
SCHEMBL5970050 0.86 FAAH (0.61) TACR1PTPRAMEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL3950971 0.85 TACR1 (0.75) TACR1MEN1KMT2AMAPTKDM4E
Hydrochloric Acid SCHEMBL29401116 0.85 TACR1 (0.75) TACR1MEN1KMT2AMAPTKDM4E
Hydrochloric Acid SCHEMBL4685036 0.85 TACR1 (0.75) TACR1MEN1KMT2AMAPTKDM4E
Hydrochloric Acid SCHEMBL28897384 0.85 TACR1 (0.75) TACR1MEN1KMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0593559-A1 AROMATIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY MERCK SHARP & DOHME LTD. (GB) 1994-04-27 — — EP claimed
WO-1993001169-A2 AROMATIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY MERCK SHARP & DOHME LIMITED (GB) 1993-01-21 — — WO claimed
US-6329394-B1 5HT3 ANTAGONIST AND NK1 RECEPTORS SUBSTANCE P ANTAGONISTS AND OTHER NEUROKININ ANTAGONISTS, IN THE TREATMENT OF EMESIS. GLAXO GROUP LIMITED (GB) 2001-12-11 — — US disclosed
EP-0819005-A4 2-ACYLAMINOPROPANAMIDES AS TACHYKININ RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2001-03-21 — — EP disclosed
EP-0819005-A1 2-ACYLAMINOPROPANAMIDES AS TACHYKININ RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1998-01-21 — — EP disclosed
US-5565568-A USEFUL IN TREATMENT OR PREVENTION OF A PHYSIOLOGICAL DISORDER ASSOCIATED WITH AN EXCESS OF TACHYKININS ELI LILLY AND COMPANY (US) 1996-10-15 — — US disclosed
WO-1996031214-A1 2-ACYLAMINOPROPANAMIDES AS TACHYKININ RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1996-10-10 — — WO disclosed
US-5547964-A ANTIEMETIC DURING DRUG THERAPY GLAXO GROUP LIMITED (GB) 1996-08-20 — — US disclosed
US-5472978-A Tachykinin antagonists for treating pain, migraine and antiinflammatory agents MERCK SHARP & DOHME LTD. (GB) 1995-12-05 — — US disclosed
EP-0615751-A1 Use of tachykinin antagonists in the treatment of emesis GLAXO GROUP LIMITED (GB) 1994-09-21 — — EP disclosed
EP-0593559-A1 AROMATIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY MERCK SHARP & DOHME LTD. (GB) 1994-04-27 — — EP disclosed
WO-1993001169-A2 AROMATIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY MERCK SHARP & DOHME LIMITED (GB) 1993-01-21 — — WO disclosed
Send feedback